Nanobac Pharmaceuticals Incorporated (NNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 12-1995 | 12-1994 | 12-1993 | 12-1992 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,240 | -830 | 190 | -100 | -239 |
| Depreciation Amortization | 1,210 | 880 | 560 | 500 | 457 |
| Other Working Capital | N/A | N/A | N/A | N/A | -85 |
| Other Operating Activity | 490 | -350 | -90 | -60 | -41 |
| Operating Cash Flow | $460 | $-300 | $660 | $340 | $94 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -117 |
| Other Investing Activity | -790 | -1,330 | -540 | -40 | -27 |
| Investing Cash Flow | $-790 | $-1,330 | $-540 | $-40 | $-145 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 300 | 270 | 1,380 | -380 | 113 |
| Financing Cash Flow | $300 | $270 | $1,380 | $-380 | $113 |
| Beginning Cash Position | 120 | 1,490 | -7 | 70 | 8 |
| End Cash Position | 100 | 120 | 1,490 | -7 | 70 |
| Net Cash Flow | $-20 | $-1,360 | $1,500 | $-70 | $62 |
| Free Cash Flow | |||||
| Operating Cash Flow | 460 | -300 | 660 | 340 | 94 |
| Free Cash Flow | 460 | -300 | 660 | 340 | 94 |